AI assistant
PRO MEDICUS LIMITED — Capital/Financing Update 2020
Aug 20, 2020
65579_rns_2020-08-20_8769ff30-c212-49f5-b9f6-fea09ab3ffe3.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
PRO MEDICUS LIMITED
Announcement Type
New announcement
Date of this announcement
Friday August 21, 2020
The Proposed issue is:
==> picture [8 x 8] intentionally omitted <==
A placement or other type of issue
Total number of +securities proposed to be issued for a placement or other type of issue
Maximum Number of ASX +security code +Security description +securities to be issued PMEAI PERFORMANCE RIGHTS 174,738
Proposed +issue date
Friday August 21, 2020
Refer to next page for full details of the announcement
Proposed issue of securities
1 / 5
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 1 - Entity and announcement details
1.1 Name of +Entity
PRO MEDICUS LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
1.2 Registered Number Type
ABN
Registration Number
25006194752
1.3 ASX issuer code
PME
1.4 The announcement is
==> picture [8 x 9] intentionally omitted <==
New announcement
1.5 Date of this announcement
Friday August 21, 2020
1.6 The Proposed issue is:
==> picture [8 x 8] intentionally omitted <==
A placement or other type of issue
Proposed issue of securities
2 / 5
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 7 - Details of proposed placement or other issue
Part 7A - Conditions
7A.1 - Are any of the following approvals required for the placement or other type of issue? +Security holder approval Court approval Lodgement of court order with +ASIC ACCC approval FIRB approval Another approval/condition external to the entity
==> picture [8 x 8] intentionally omitted <==
No
Part 7B - Issue details
Is the proposed security a 'New Will the proposed issue of this class' (+securities in a class that is +security include an offer of not yet quoted or recorded by ASX) attaching +securities? or an 'Existing class' (additional No securities in a class that is already quoted or recorded by ASX)? Existing class
Details of +securities proposed to be issued
ASX +security code and description
PMEAI : PERFORMANCE RIGHTS
Number of +securities proposed to be issued
174,738
Offer price details
Are the +securities proposed to be issued being issued for a cash consideration? No
Please describe the consideration being provided for the +securities
Nil, unless employment ceases before vesting period elapses
Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities
Proposed issue of securities
3 / 5
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? No
If some of the issued +securities do not rank equally Is the actual date from which the +securities will rank equally (non-ranking Provide the actual non-ranking end end date) known? date Yes Monday August 30, 2021
Please state the extent to which the +securities do not rank equally: In relation to the next dividend, distribution or interest payment; or For any other reason
Do not rank equally until the 12 month vesting period elapses
Part 7C - Timetable
7C.1 Proposed +issue date Friday August 21, 2020
Part 7D - Listing Rule requirements
7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? No
7D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1?
==> picture [8 x 8] intentionally omitted <==
Yes
7D.1b ( i ) How many +securities are proposed to be issued without security holder approval using the entity's 15% placement capacity under listing rule 7.1?
174,738 performance rights
7D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? No
7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No
7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules? Yes
7D.3a Please enter, the number and +class of the +restricted securities and the date from which they will cease to be +restricted securities
174,738 performance rights are restricted until 12 months vesting period elapses
7D.4 Will any of the +securities to be issued be subject to +voluntary escrow? No
Proposed issue of securities
4 / 5
Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 7E - Fees and expenses
7E.1 Will there be a lead manager or broker to the proposed issue? No 7E.2 Is the proposed issue to be underwritten? No
7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue
Part 7F - Further Information
7F.01 The purpose(s) for which the entity is issuing the securities
Issued pursuant to granting of performance rights
7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds? No
7F.2 Any other information the entity wishes to provide about the proposed issue
Proposed issue of securities
5 / 5